Clinical Trials · NCT07820111

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Phase
Phase 3
Recruitment status
Completed
Sponsor
Zagazig University
Enrollment
159
Start date
Oct 2025
Locations
1 site, Saudi Arabia
Primary endpoint
change in body weight at 3 and 6 months
View Tirzepatide compound reference